Compassion Behavioral Health -Mental Health Treatment Hollywood, FL
1701 Mayo Street, Hollywood
4.8(265 Google reviews)
United States
6 listed treatment centers serving Hollywood and the surrounding area.
1701 Mayo Street, Hollywood
4.8(265 Google reviews)
4000 Hollywood Boulevard, 715S, Hollywood
4.4(208 Google reviews)
4000 Hollywood Boulevard, 715S, Hollywood
4.7(51 Google reviews)
110 North Federal Highway, 302, Hallandale Beach
3.9(7 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Hollywood.
1.3 miles away · Hallandale Beach
4.1 miles away · Aventura
2999 Northeast 191st Street, Suite 200, Aventura
4.8(32 Google reviews)
4.1 miles away · Aventura
4.9 miles away · Miami
6.5 miles away · Miramar
7 miles away · Davie
5595 South University Drive, Davie
3.8(56 Google reviews)
For people in Hollywood considering SPRAVATO®, understanding the full visit cost matters as much as checking medication coverage. Both the medication and the observed treatment and monitoring visit may be billed. Ask for a written estimate that separates these services and explains your expected out-of-pocket responsibility. An estimate is not a guarantee of what your insurer will pay.
Prior authorization is common. Your insurer may request documentation of earlier antidepressant trials before deciding whether to approve treatment. Ask the treatment center which records it needs, who submits the authorization request, and how you will learn the decision. Gathering records from previous prescribers may help the center prepare its submission.
Medicare coverage may fall under Part B or Part D, depending on the plan and treatment setting. Florida Medicaid coverage also depends on the plan and setting. Neither program’s potential coverage means a particular center accepts it; confirm both coverage and participation directly.
Manufacturer savings programs exist for eligible commercially insured patients, not patients using government insurance. Ask about current eligibility rules and which charges any assistance applies to.
Before scheduling, ask the center and your insurer:
Clarifying these details early can help you plan without assuming approval or a fixed cost.
SPRAVATO® is administered only in a healthcare setting certified through the SPRAVATO® REMS program. You self-administer the nasal spray under a healthcare provider’s direct observation; it is never sent home with you. A directory listing alone does not confirm certification, so verify the location’s current status before booking.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, then weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber individualizes the schedule; do not assume that your appointments will follow a fixed pattern.
Reserve more than a two-hour window. Monitoring lasts at least two hours after each dose, and check-in, preparation, and readiness-to-leave assessments can add time. Ask the center how much time to set aside, then discuss recurring time off or schedule adjustments with your employer as needed.
Arrange for someone else to drive you home after every visit. You must not drive or operate machinery until the next day after a restful sleep. Confirm your ride before treatment and have a backup plan. If relying on a ride service, ask the center about its pickup and escort requirements before making arrangements.
Hollywood has listed treatment options. If you cannot find an available Hollywood listing or a suitable appointment, you can also check listings in Hallandale Beach or Aventura; Miami and West Palm Beach have listings as well. Confirm certification, availability, insurance participation, and transportation arrangements at each location rather than assuming the listing establishes these details.
Start with the Hollywood listings, then contact the location to confirm that it currently provides SPRAVATO® and is certified through the SPRAVATO® REMS program. Certification is not confirmed in the supplied listing information. Ask whether the center is accepting new patients and what its evaluation process involves. If needed, check listed options in Hallandale Beach or Aventura.
SPRAVATO® is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A prescriber must assess your diagnosis, treatment history, and safety considerations; a listing cannot establish eligibility.
Coverage for SPRAVATO® depends on your plan and the treatment setting. Prior authorization and records of previous antidepressant trials are common requirements. Medicare and Florida Medicaid may cover treatment depending on the plan and setting, but you must also confirm that the center accepts your coverage. Ask about both medication and monitoring charges before starting.
During a SPRAVATO® visit, you use the nasal spray yourself under direct observation at a REMS-certified healthcare setting. Staff monitor you for at least two hours after the dose for effects such as sedation, dissociation, breathing problems, and blood pressure increases. The full appointment may take longer. Someone else must drive you home, and driving is prohibited until the next day after restful sleep.
SPRAVATO® carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. Dissociation can feel like being disconnected from yourself or your surroundings. Blood pressure can also increase. It is a Schedule III controlled substance. Discuss your health history, medications, and substance-use history with the prescriber so they can assess risks and explain monitoring.
No. In a crisis, call or text 988; call 911 for immediate danger or a medical emergency. Although SPRAVATO® has an approved use for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, it has not been shown to prevent suicide or reduce suicidal thoughts or behavior. It does not replace hospitalization when clinically needed.
Approved uses, nearby treatment centers, and medically sourced patient guides.